➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Colorcon
Johnson and Johnson

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084146


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 084146 describes SODIUM SULFACETAMIDE, which is a drug marketed by Akorn and Sola Barnes Hind and is included in five NDAs. Additional details are available on the SODIUM SULFACETAMIDE profile page.

The generic ingredient in SODIUM SULFACETAMIDE is sulfacetamide sodium. There are three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 084146
Tradename:SODIUM SULFACETAMIDE
Applicant:Sola Barnes Hind
Ingredient:sulfacetamide sodium
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084146

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength30%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Harvard Business School
Dow
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.